Home / Inspections / 1079179

FDA Inspection 1079179 — Acorda Therapeutics, Inc.

Acorda Therapeutics, Inc. — FEI 3002457563

The FDA completed an inspection of Acorda Therapeutics, Inc. on January 18, 2019 in Pearl River, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 18, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Pearl River, NY (United States)

Additional Details

Sponsor, Contract Research Organization

Facility

Other inspections at this facility

  • 1130049 (NAI Tue Aug 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1100682 (NAI Fri Jul 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 975465 (VAI Mon Feb 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 892026 (VAI Mon Aug 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 860326 (VAI Thu Dec 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources